Bausch Health Companies I... (BHC)
Bausch Health Companies Statistics
Share Statistics
Bausch Health Companies has 367.93M shares outstanding. The number of shares has increased by 0.65% in one year.
Shares Outstanding | 367.93M |
Shares Change (YoY) | 0.65% |
Shares Change (QoQ) | 0.19% |
Owned by Institutions (%) | 68.73% |
Shares Floating | 289.91M |
Failed to Deliver (FTD) Shares | 100 |
FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 8.25M, so 2.24% of the outstanding shares have been sold short.
Short Interest | 8.25M |
Short % of Shares Out | 2.24% |
Short % of Float | 2.84% |
Short Ratio (days to cover) | 6.24 |
Valuation Ratios
The PE ratio is -64.48 and the forward PE ratio is 1.72. Bausch Health Companies's PEG ratio is 0.38.
PE Ratio | -64.48 |
Forward PE | 1.72 |
PS Ratio | 0.31 |
Forward PS | 0.3 |
PB Ratio | -2.32 |
P/FCF Ratio | 2.35 |
PEG Ratio | 0.38 |
Enterprise Valuation
Bausch Health Companies Inc. has an Enterprise Value (EV) of 24.37B.
EV / Earnings | -529.73 |
EV / Sales | 2.56 |
EV / EBITDA | 15.76 |
EV / EBIT | 15.76 |
EV / FCF | 19.34 |
Financial Position
The company has a current ratio of 0.86, with a Debt / Equity ratio of -2.09.
Current Ratio | 0.86 |
Quick Ratio | 0.62 |
Debt / Equity | -2.09 |
Total Debt / Capitalization | 191.68 |
Cash Flow / Debt | 0.6 |
Interest Coverage | 1.11 |
Financial Efficiency
Return on equity (ROE) is 0.04% and return on capital (ROIC) is -28.34%.
Return on Equity (ROE) | 0.04% |
Return on Assets (ROA) | 0% |
Return on Capital (ROIC) | -28.34% |
Revenue Per Employee | $459,806.76 |
Profits Per Employee | $-2,222.22 |
Employee Count | 20,700 |
Asset Turnover | 0.36 |
Inventory Turnover | 1.74 |
Taxes
Income Tax | 239M |
Effective Tax Rate | 1.43 |
Stock Price Statistics
The stock price has increased by -35.18% in the last 52 weeks. The beta is 0.6, so Bausch Health Companies's price volatility has been higher than the market average.
Beta | 0.6 |
52-Week Price Change | -35.18% |
50-Day Moving Average | 7.14 |
200-Day Moving Average | 7.29 |
Relative Strength Index (RSI) | 42.59 |
Average Volume (20 Days) | 2.63M |
Income Statement
In the last 12 months, Bausch Health Companies had revenue of 9.52B and earned -46M in profits. Earnings per share was 1.1.
Revenue | 9.52B |
Gross Profit | 6.74B |
Operating Income | 1.55B |
Net Income | -46M |
EBITDA | 1.55B |
EBIT | 1.55B |
Earnings Per Share (EPS) | 1.1 |
Balance Sheet
The company has 1.18B in cash and 2.67B in debt, giving a net cash position of -1.49B.
Cash & Cash Equivalents | 1.18B |
Total Debt | 2.67B |
Net Cash | -1.49B |
Retained Earnings | -9.82B |
Total Assets | 26.52B |
Working Capital | -978M |
Cash Flow
In the last 12 months, operating cash flow was 1.6B and capital expenditures -337M, giving a free cash flow of 1.26B.
Operating Cash Flow | 1.6B |
Capital Expenditures | -337M |
Free Cash Flow | 1.26B |
FCF Per Share | 3.42 |
Margins
Gross margin is 70.77%, with operating and profit margins of 16.24% and -0.48%.
Gross Margin | 70.77% |
Operating Margin | 16.24% |
Pretax Margin | 1.75% |
Profit Margin | -0.48% |
EBITDA Margin | 16.24% |
EBIT Margin | 16.24% |
FCF Margin | 13.24% |
Dividends & Yields
BHC pays an annual dividend of $1.37, which amounts to a dividend yield of 4.99%.
Dividend Per Share | $1.37 |
Dividend Yield | 4.99% |
Dividend Growth (YoY) | -76% |
Payout Ratio | -1053.85% |
Earnings Yield | 16.18% |
FCF Yield | 50.36% |
Analyst Forecast
The average price target for BHC is $8, which is 17.6% higher than the current price. The consensus rating is "Hold".
Price Target | $8 |
Price Target Difference | 17.6% |
Analyst Consensus | Hold |
Analyst Count | 5 |
Stock Splits
The last stock split was on Oct 16, 2000. It was a forward split with a ratio of 2:1.
Last Split Date | Oct 16, 2000 |
Split Type | forward |
Split Ratio | 2:1 |
Scores
Altman Z-Score | 0.05 |
Piotroski F-Score | 4 |